0.000USD0.000Pre-market 08/03, 09:30 (ET)
439.47MMarket Cap
LossP/E TTM
Key Figures
13.740Open
13.740High
332.03KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.98%Turnover Ratio
13.750Prev. Close
12.660Low
3.37MTurnover
LossP/E Static
30.24P/B
0.00%Div Yield TTM
-20.63%ROA
19.60052wk High
1.35Volume Ratio
-27.14MNet Profit
33.91MShares
-0.6451EPS TTM
1.91Beta
-111.38%ROE
7.56352wk Low
7.85%Amplitude
81.78%Gross Margin
439.47MMarket Cap
-6.43Reward/Risk
3.21%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Neuropace Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 52 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 20.22.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Neuropace Inc Highlights
StrengthsRisks
Neuropace Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Neuropace Inc Info
NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.
Ticker SymbolNPCE
CompanyNeuropace Inc
CEOBecker (Joel D)
Websitehttps://www.neuropace.com/
Shareholders
FAQs
What is the current price of Neuropace Inc (NPCE)?
The current price of Neuropace Inc (NPCE) is 12.89.
What is the symbol of Neuropace Inc?
The ticker symbol of Neuropace Inc is NPCE.
What is the 52-week high of Neuropace Inc?
The 52-week high of Neuropace Inc is 19.60.
What is the 52-week low of Neuropace Inc?
The 52-week low of Neuropace Inc is 7.56.
What is the market capitalization of Neuropace Inc?
The market capitalization of Neuropace Inc is 439.47M.
Is Neuropace Inc (NPCE) currently rated as Buy, Hold, or Sell?
According to analysts, Neuropace Inc (NPCE) has an overall rating of Buy, with a price target of 20.22.
What is the Earnings Per Share (EPS TTM) of Neuropace Inc (NPCE)?
The Earnings Per Share (EPS TTM) of Neuropace Inc (NPCE) is -0.66.